Cancer Genomics is an advanced form of clinical testing that involves predicting the chances of cancer in an individual at a future stage. Cancer genomics screening can help in early detection and preparation for critical health troubles in the future.
At Phoenix Med Lab, we scrounge for deep genomic insights that help physicians in prevention, detection and developing accurate treatment plans for cancer.
Our cancer genomics testing solutions help in screening hereditary mutations or conditions that signify predisposition to certain types of cancer.
Improve the quality of cancer care and create personalized cancer therapy and treatment plans based on patient’s genomics profile.
Our services cover a wide range of blood profiles personalized according to the diagnostic needs.
ATM, BARD1, BRCA1, BRCA2, BRIP1, NBN, NF1, PALB2, RAD50, RAD51C, RAD51D, STK11, CHEK2, TP53, PTEN, APM2, MLH1, MSH2, MSH6, PMS2, EPCAM, DICER1, SMARC4A, APC, BMPR1A, CDKN2A, MEN1, SMAD4, VHL, TSC1, TSC2, WT1, GREM1, CDH1, AXIN2, MUTYH, POLD1, BAP1, PTCH1, MET, CDC73, CDKN1C, DIS3L2, FH, FLCN, GPC3, PRKAR1A, RB1, REQL4, SDHA, SDHB, SDHC, SDHD, SUFU, RET (55 genes)
ATM, BARD1, BRCA1, BRCA2, BRIP1, NBN, NF1, PALB2, RAD50, RAD51C, RAD51D, STK11, CHEK2, TP53, PTEN, CDH1 (16 genes)
ATM, BARD1, BRCA1, BRCA2, BRIP1, NBN, NF1, PALB2, RAD50, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2, EPCAM, STK11, CHEK2, TP53, PTEN, CDH1, DICER1, SMARC4A (23 genes
APC, ATM, BMPR1A, BRCA1, BRCA2, CDKN2A, MEN1, NBN, PALB2, SMAD4, MLH1, MSH2, PMS2, EPCAM, STK11, TP53, VHL, TSC1, TSC2, WT1 (20 genes)
ATM, BRCA1, BRCA2, NBN, MLH1, MSH2, MSH6, PMS2, EPCAM, CHEK2, TP53, APM2 (12 genes)
APC, BMPR1A, SMAD4, MLH1, MSH2, MSH6, PMS2, EPCAM, STK11, CHEK2, TP53, PTEN, CDH1, AXIN2, GREM1, MUTYH, POLD1 (17 genes)
MET, PTCH1, MLH1, MSH2, MSH6, PMS2, EPCAM, TP53, PTEN, VHL, DICER1, BAP1, CDC73, CDKN1C, DIS3L2, FH, FLCN, GPC3, PRKAR1A, RB1, REQL4, SDHA, SDHB, SDHC, SDHD, SUFU, APM2 (27 genes)
Go through Deep Predictive Insights in Routine Genomics Reports
Download a Sample Report